Vinay Prasad on Patient Advocacy Groups as Industry Fronts: warns against

What Prasad says

Dr. Vinay Prasad warns that many patient advocacy groups represent pharmaceutical industry interests rather than patients’. He makes the claim in the Get the Check podcast interview (~August 2026, timestamp ~1:05:10), arguing it undercuts their role in regulatory debates.

His stated reasoning

Prasad’s stated reasoning is that when advocacy organizations take industry funding, their pressure on regulators — to approve drugs faster or keep them on the market — serves sponsors’ interests rather than patients’. That, he says, distorts the regulatory process while wearing the moral authority of the patient voice.

This page chronicles a stated position of the person above. It is not medical advice and not the site's own conclusion.